Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Alan Nurden: Looking Beyond Bleeding in VWD
Alan Nurden/Photo: issue.com
Feb 11, 2026, 15:57

Alan Nurden: Looking Beyond Bleeding in VWD

Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared on LinkedIn about a recent article by Dawn Swan et al, published in RPTH Journal:

”A well thought-out and much-needed assessment of the effects of VWD extending beyond the classical bleeding symptoms.

Could someone now do this for the platelet-based bleeding disorder, Glanzmann thrombasthenia (GT)?

And for GT it would be interesting to go beyond well-studied European and North American populations to include Arab, Pakistani, Indian, Chinese, African and South-American populations where cultural and religious heritage may have a bearing on lifestyle.

A complication of GT is that two genes are involved (ITGA2B and ITGB3) and despite hints from older studies the question of whether ITGB3 defects that lead to both alphaIIbbeta3 and alphavbeta3 deficiencies can influence such parameters as bone density and fertility remain unresolved.”

Title: Von Willebrand disease: more than just a bleeding disorder

Authors: Dawn Swan, Michelle Sholzberg, Bethany Samuelson Bannow, Jecko Thachil

Read the Full Article on RPTH Journal

Alan Nurden: Looking Beyond Bleeding in VWD

Stay updated on all scientific advances with Hemostasis Today.

Alan Nurden Bethany Samuelson Bannow bleeding disorders Dawn Swan Glanzmann thrombasthenia GT Health Hematology Hemostasis Hemostasis News Hemostasis Today ITGA2B ITGB3 Jecko Thachil Medicine Michelle Sholzberg rpth VWD VWF
NewsFeed